IL33 and myeloid sarcoma: IL-33 is related to pathogenic mechanisms in neurodegenerative disorders such as Parkinson’s disease (PD), Alzheimer’s disease (AD), multiple sclerosis (MS), Huntington’s disease (HD), chronic traumatic encephalopathy (CTE), and amyotrophic lateral sclerosis (ALS).